mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.004 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.004 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.004 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
necrostatin-7 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.006 |